Advertisement
Screener

Adicet Bio, Inc. (ACET) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Adicet Bio, Inc. Cash Flow Breakdown

Cash flow breakdown shows where Adicet Bio, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $95.25M went out.
  • Fiscal year ended 2025-12-31: from investing, $2.39M came in.
  • Fiscal year ended 2025-12-31: from financing, $75.25M came in.
  • Fiscal year ended 2025-12-31: change in cash, $17.61M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingStaff share taxNew shares soldNot split outChange in cash
2025-12-31-$95.25M$2.39M-$104.00K$0.00$75.35M*-$17.61M
2024-12-31-$92.38M-$119.24M-$141.00K$19.27M$92.18M*-$100.31M
2023-12-31-$93.72M-$4.46M-$150.00K$0.00-$97.94M
2022-12-31-$44.77M-$16.78M-$3.23M$43.36M$1.38M*-$20.04M
2021-12-31-$51.05M-$2.80M$238.13M$4.56M*$188.84M
2020-12-31-$41.55M$115.22M$460.00K$73.97M
2019-12-31-$27.88M-$47.93M$30.00K$76.92M*$1.13M
2018-12-31-$18.18M-$16.06M$221.00K$10.82M*-$23.19M
2017-12-31-$10.98M-$44.00K$64.38M*$53.35M

Each quarter (3 month)

Quarter endRunning the businessFrom investingCommercial paperStaff share taxNew shares soldNot split outChange in cash
2026-06-30-$19.82M*$16.65M*$0.00*-$3.00K
2026-03-31-$21.49M$18.88M$100.00K-$65.00K-$2.68M
2025-12-31-$20.91M*-$44.53M*$0.00*$75.23M*
2025-09-30-$22.31M*$16.84M*$0.00*$0.00*
2025-06-30-$26.63M*$32.95M*$0.00*$0.00*
2025-03-31-$25.40M-$2.86M-$104.00K-$28.36M
2024-12-31-$24.10M*-$22.12M*$0.00*
2024-09-30-$22.01M*-$96.58M*$0.00*
2024-06-30-$23.42M*-$302.00K*$0.00*
2024-03-31-$22.85M-$239.00K-$141.00K$19.27M$91.84M*$87.88M
2023-12-31-$23.49M*-$136.00K*$0.00*
2023-09-30-$21.24M*-$906.00K*-$59.00K$0.00*
2023-06-30-$24.90M*-$1.51M*$0.00*
2023-03-31-$24.09M-$1.92M-$10.00K$0.00-$26.02M
2022-12-31-$18.84M*-$6.49M*$0.00*
2022-09-30-$15.33M*-$4.81M*-$1.35M$43.36M*
2022-06-30-$14.71M*-$2.85M*-$203.00K$183.00K*
2022-03-31$4.11M-$2.63M-$1.11M$94.00K$339.00K
2021-12-31-$13.44M*-$3.08M*$94.38M*$3.09M*
2021-09-30-$9.68M*-$7.18M*$0.00*
2021-06-30-$12.78M*-$382.00K*$0.00*
2021-03-31-$15.15M$7.84M$143.75M$1.13M*$137.58M
2020-12-31-$13.35M*$12.45M*$267.00K*
2020-09-30-$7.85M*$74.65M*$144.00K*
2020-06-30-$12.01M*$23.68M*-$1.00K*$7.00K*
2020-03-31-$8.35M$4.45M$42.00K-$3.87M
2019-12-31-$7.26M*-$5.01M*$0.00*$6.00K*
2019-09-30$5.60M*-$33.27M*-$11.00K*$26.71M*$2.25M*
2019-06-30-$14.18M*$24.98M*$3.55M*$14.19M*
2019-03-31-$12.05M-$34.63M$46.82M*$139.00K
2018-12-31$9.63M*$76.57M*-$78.89M*-$15.81M*
2018-09-30-$10.72M*-$17.78M*-$28.50M*
2018-06-30-$9.78M*-$74.57M*-$84.35M*
2018-03-31-$7.30M-$278.00K$89.94M*$82.36M
2017-12-31-$4.99M*-$5.00K*$54.38M*$49.38M*
2017-09-30-$3.86M*$12.00K*$4.50M*$655.00K*
2017-03-31-$294.00K

Similar stocks

Stock NameCountryMarket CapPE Ratio
Valion Bio, Inc. (VBIO)United States$0.077B
Lifevantage Corp (LFVN)United States$0.078B15.40
MAIA Biotechnology, Inc. (MAIA)United States$0.077B-2.30
iBio, Inc. (IBIO)United States$0.077B-2.94
Verrica Pharmaceuticals Inc. (VRCA)United States$0.076B-3.39
OS Therapies Inc (OSTX)United States$0.076B-2.17
Gain Therapeutics, Inc. (GANX)United States$0.080B-4.40
Aldeyra Therapeutics, Inc. (ALDX)United States$0.074B-5.57
Cingulate Inc. (CING)United States$0.073B-2.64
Spero Therapeutics, Inc. (SPRO)United States$0.073B17.41